ResearcherShanghai Medical College of Fudan UniversityNo recent work listed
Pengyuan Yang
Matched on ORCID iD 0000-0001-5779-1008; OpenAlex author ID A5057539657. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 19
2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 1 paper
Papers 7
- Rapid sample preparation workflow based on enzymatic nanoreactors for potential serum biomarker discovery in pancreatic cancer. Co-author DOI 10.1016/j.talanta.2021.123018↗
- LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer. Last author DOI 10.1016/j.cca.2020.03.043↗
- WD repeat-containing protein 1 maintains β-Catenin activity to promote pancreatic cancer aggressiveness. Co-author DOI 10.1038/s41416-020-0929-0↗
- A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pancreatic Cancer. Co-author DOI 10.21873/cgp.20114↗
- A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline. Last author DOI 10.1038/bjc.2017.365↗
- Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-based quantitative proteomics. Co-author DOI 10.1016/j.jprot.2013.03.031↗
- iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.jprot.2013.06.032↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaohui Liu · 5 shared papers, 2013–2022 · strength 0.41
- Paper Rapid sample preparation workflow based on enzymatic nanoreactors for potential serum biomarker discovery in pancreatic… DOI 10.1016/j.talanta.2021.123018↗
- Paper WD repeat-containing protein 1 maintains β-Catenin activity to promote pancreatic cancer aggressiveness. DOI 10.1038/s41416-020-0929-0↗
- Paper A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline. DOI 10.1038/bjc.2017.365↗
- Yueting Xiong · 3 shared papers, 2019–2022 · strength 0.40
- Paper Rapid sample preparation workflow based on enzymatic nanoreactors for potential serum biomarker discovery in pancreatic… DOI 10.1016/j.talanta.2021.123018↗
- Paper LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer. DOI 10.1016/j.cca.2020.03.043↗
- Paper A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pan… DOI 10.21873/cgp.20114↗
- Hengchao Li · 3 shared papers, 2019–2022 · strength 0.35
- Paper Rapid sample preparation workflow based on enzymatic nanoreactors for potential serum biomarker discovery in pancreatic… DOI 10.1016/j.talanta.2021.123018↗
- Paper WD repeat-containing protein 1 maintains β-Catenin activity to promote pancreatic cancer aggressiveness. DOI 10.1038/s41416-020-0929-0↗
- Paper A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pan… DOI 10.21873/cgp.20114↗
- Yishen Mao · 2 shared papers, 2019–2020 · strength 0.20
- Deliang Fu · 2 shared papers, 2019–2020 · strength 0.20
- Chenxin Zhu · 1 shared paper, 2022 · strength 0.16
- Lei Zhang · 1 shared paper, 2022 · strength 0.16
- Wansheng Wang · 3 shared papers, 2013–2017 · strength 0.16
- Paper A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline. DOI 10.1038/bjc.2017.365↗
- Paper Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-bas… DOI 10.1016/j.jprot.2013.03.031↗
- Paper iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma. DOI 10.1016/j.jprot.2013.06.032↗
- Wenhui Lou · 2 shared papers, 2013–2017 · strength 0.11
- Jichun Gu · 1 shared paper, 2020 · strength 0.10
- Lie Yao · 1 shared paper, 2020 · strength 0.10
- Chen Jin · 1 shared paper, 2020 · strength 0.10
- Yongjian Jiang · 1 shared paper, 2020 · strength 0.10
- Ji Li · 1 shared paper, 2020 · strength 0.10
- Di Yang · 1 shared paper, 2020 · strength 0.10
- Shu‐Heng Jiang · 1 shared paper, 2020 · strength 0.10
- Dayong Jin · 2 shared papers, 2013 · strength 0.08
- Paper Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-bas… DOI 10.1016/j.jprot.2013.03.031↗
- Paper iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma. DOI 10.1016/j.jprot.2013.06.032↗
- Xiao-Lin Wang · 2 shared papers, 2013 · strength 0.08
- Paper Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-bas… DOI 10.1016/j.jprot.2013.03.031↗
- Paper iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma. DOI 10.1016/j.jprot.2013.06.032↗
- Xiaolin Wang · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.